The Australian office was established in 2001 with the first direct employee in 2002.  The head office is in Belrose, Sydney and since establishment has expanded and there are now more than 30 direct employees.

With a specific focus on rare and orphan diseases, the passionate and dedicated team always make sure that the patient is at the heart of everything they do. The commitment to science as a means to serve unmet medical needs and the drive to continue to develop effective therapies within this domain is strong and inherent in all the activities undertaken by the company.

As a biopharma company, Actelion Pharmaceuticals Australia is fairly small with relatively few staff, therefore each single member of the team is essential to the success of the affiliate. Everyone is fully accountable for their responsibilities, which empowers employees to the maximum extent and allows everyone to take part in the continuous development of the company.